Page last updated: 2024-08-24

cidofovir anhydrous and Disease Models, Animal

cidofovir anhydrous has been researched along with Disease Models, Animal in 77 studies

Research

Studies (77)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	17 (22.08)	18.2507
2000's	41 (53.25)	29.6817
2010's	17 (22.08)	24.3611
2020's	2 (2.60)	2.80

Authors

Authors	Studies
Buller, RM; Hruby, DE; Jordan, R; Keith, KA; Kern, ER; Parker, S; Quenelle, DC	1
Borysko, K; Breitenbach, J; Drach, JC; Hilfinger, J; Kashemirov, BA; Kijek, P; Kim, JS; McKenna, CE; Mitchell, S; Peterson, LW	1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV	1
Heery, GP; Paull, JRA; Romanowski, EG; Shanks, RMQ; Yates, KA	1
Spencer, JF; Tollefson, AE; Toth, K; Wold, WSM; Ying, B	1
Achdout, H; Erez, N; Israeli, O; Israely, T; Lustig, S; Melamed, S; Paran, N; Politi, B; Tamir, H; Waner, T	1
Andrei, G; Brisse, E; Imbrechts, M; Matthys, P; Mitera, T; Snoeck, R; Vandenhaute, J; Wouters, CH	1
Choo, DI; Nassar, M; Reece, AL; Sidell, DR; Ward, JA	1
Andrei, G; De Schutter, T; Duraffour, S; Matthys, P; Mitera, T; Snoeck, R; Topalis, D; van den Oord, J	1
Damon, IK; Foster, S; Gates, I; Lanier, ER; Li, Y; Olson, VA; Smith, SK; Trost, LC	1
Dagley, A; Downs, B; Hagloch, J; Smee, DF; Tarbet, EB	1
Black, DH; Brush, LA; Eberle, R; Maxwell, LK; Mccormack, KA; Payton, ME; Ritchey, JW; Wright, G	1
Buller, RM; Spencer, JF; Tollefson, AE; Toth, K; Wold, WS; Ying, B	1
Foster, SA; Godin, SJ; Keilholz, L; Khouri, J; Long, J; Rose, ML; Trost, LC	1
Judd, BE; Ledbetter, EC; Mohammed, HO; Pennington, MR; Spertus, CB; Van de Walle, GR	1
Ahmed, MM; Connor, MP; Howard, NS; Lospinoso, J; Maturo, SC; O'Connor, P; Palazzolo, M; Thompson, ME	1
Bellacicco, AL; Buonavoglia, C; Camero, M; Crescenzo, G; Decaro, N; Martella, V; Neyts, J; Tarsitano, E; Tempesta, M	1
Buller, RM; Huso, DL; Sagartz, JE; Schultz, DA	1
Smee, DF	1
Inoue, H; Ishikawa, M; Kadonosono, K; Sonoda, KH; Uchio, E	1
Gordon, YJ; Romanowski, EG; Yates, KA	2
Bhattacharjee, PS; Capriotti, JA; Clement, C; Foster, TP; Hill, JM; Hobden, JA; Kumar, M; Liang, B; Mahmud, R; Thompson, HW	1
Armenise, C; Bellacicco, AL; Buonavoglia, C; Camero, M; Crescenzo, G; Marinaro, M; Tarsitano, E; Tempesta, M	1
Didier, PJ; Doyle, LA; Killeen, SZ; Marx, PA; Reddy, JD; Roy, CJ; Sivasubramani, SK; Talton, JD; Verreault, D	1
Erez, N; Israely, T; Lustig, S; Melamed, S; Paran, N; Politi, B; Shafferman, A	1
Liekens, S	1
Sidwell, RW; Smee, DF	1
Bolger, GT; Bousquet, C; Cordingley, MG; Garneau, M; Kibler, P; Tremblay, F	1
Collins, DJ; Kern, ER; Quenelle, DC	2
Abe, M; Aoki, K; Iida, T; Kaneko, H; Mori, S; Ohno, S; Shigeta, S; Suzuki, O; Suzutani, T	1
Beadle, JR; Buller, RM; Hostetler, KY; Melman, L; Owens, G; Schriewer, J	1
De Clercq, E; Leyssen, P; Neyts, J; Verbeken, E	1
Bidanset, DJ; Hartline, CB; Kern, ER; Rybak, RJ	2
Beadle, JR; Bidanset, DJ; Hostetler, KY; Kern, ER; Wan, WB	1
Bailey, KW; Sidwell, RW; Smee, DF; Wandersee, MK; Wong, MH	1
De Clercq, E	2
Bailey, KW; Holy, A; Hostetler, KY; Sidwell, RW; Smee, DF; Wandersee, MK	1
Anderson, JL; McGregor, A; Schleiss, MR	1
Gordon, YJ; Irschick, EU; Nagl, M; Romanowski, EG; Teuchner, B; Yates, KA	1
Lenaerts, L; Naesens, L	1
Allen, SD; Knorr, CW; Smee, DF; Torres, AR	1
Choo, DI; Schleiss, MR; Stroup, G; White, DR	1
Evans, DH; Hostetler, KY; Kornbluth, RS; Sidwell, RW; Smee, DF; Snarsky, V	1
Bellacicco, AL; Buonavoglia, C; Camero, M; Crescenzo, G; Neyts, J; Tempesta, M; Thiry, E; Thiry, J	1
Garrison, A; Goff, A; Lawler, J; Mucker, E; Paragas, J; Twenhafel, N	1
Bernstein, DI; Bravo, FJ; Cardin, RD	1
Adams, MM; Moyer, RW; Rice, AD	1
Andrei, G; De Clercq, E; Fiten, P; Froeyen, M; Opdenakker, G; Snoeck, R	1
Gambotto, A; Gordon, YJ; Nwanegbo, EC; Romanowski, EG	1
De Clercq, E; Geboes, L; Kelchtermans, H; Lenaerts, L; Matthys, P; Naesens, L; Verbeken, E	1
Assil, KK; Bergeron-Lynn, G; Besen, G; De Clercq, E; Flores-Aguilar, M; Gangan, P; Kupperman, BD; Munguia, D; Pursley, M; Vuong, C	1
Araullo-Cruz, T; Gordon, YJ; Romanowski, EG	1
De Clercq, E; Neyts, J	1
Bruggeman, CA; de Clercq, E; Havenith, M; Stals, FS; Zeytinoglu, A	1
Bravo, FJ; Kern, ER; Kier, AB; Stanberry, LR; Vogt, PE	1
Assil, KK; Bergeron-Lynn, G; Besen, G; Connor, JD; De Clercq, E; Freeman, WR; Kuppermann, BD; Munguia, D; Pursley, M; Vuong, C; Wiley, CA	1
de Oliveira, CB; LaBree, L; McDonnell, PJ; Stevenson, D; Trousdale, MD	1
de Clercq, E; De Hauwere, B; Lutz, A; Maudgal, PC; Neyts, J	1
Bruggeman, CA; Kloover, JS; Stals, FS; Vanagt, WY	1
Banker, AS; Bergeron-Lynn, G; De Clercq, E; Flores-Aguilar, M; Freeman, WR; Keefe, K; Munguia, D; Rao, NA; Taskintuna, I; Wiley, CA	1
Kaufman, HE; Thompson, HW; Varnell, ED	1
Bolger, G; Bousquet, C; Cordingley, M; Garneau, M; Kibler, P; Lapeyre, N; Rhéaume, M	1
Cordingley, MG; De Marte, J; Duan, J; Fleet, TL; Paris, W; Roopchand, D	1
Budgeon, LR; Christensen, ND; Kreider, JW; Pickel, MD	1
Lawson, CM; Lenzo, JC; Shellam, GR	1
Bailey, KW; Sidwell, RW; Smee, DF	2
Cohen, J	1
Balzarini, J; De Clercq, E; Naesens, L; Neyts, J	1
Holy, A; Leonhardt, JA; Mead, JR; Morris, JL; Sidwell, RW; Smee, DF	1
Araullo-Cruz, T; De Clercq, E; Gordon, YJ; Romanowski, E	1
Kern, ER	1
De Clercq, E; Maudgal, PC	1

Reviews

7 review(s) available for cidofovir anhydrous and Disease Models, Animal

Article	Year
Progress in the discovery of compounds inhibiting orthopoxviruses in animal models. Antiviral chemistry & chemotherapy, 2008, Volume: 19, Issue:3 Topics: Adenine; Animals; Antiviral Agents; Benzamides; Cidofovir; Cytosine; Disease Models, Animal; Drug Discovery; Humans; Isoindoles; Organophosphonates; Orthopoxvirus; Prodrugs	2008
The role of growth factors, angiogenic enzymes and apoptosis in neovascularization and tumor growth-collected publications. Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 2002, Volume: 64, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cidofovir; Cyclohexanes; Cytosine; Disease Models, Animal; Fibroblast Growth Factor 2; Growth Substances; Hemangioma; Humans; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Organophosphonates; Organophosphorus Compounds; Rats; Sesquiterpenes; Thymidine Phosphorylase; Tumor Virus Infections	2002
A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral research, 2003, Volume: 57, Issue:1-2 Topics: Animals; Antiviral Agents; Bioterrorism; Cidofovir; Cytosine; Disease Models, Animal; Humans; Mice; Mice, SCID; Nucleosides; Organophosphonates; Organophosphorus Compounds; Orthopoxvirus; Poxviridae Infections; Rabbits; Smallpox; Thiosemicarbazones	2003
Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections. Expert review of anti-infective therapy, 2003, Volume: 1, Issue:1 Topics: Adenine; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; DNA Virus Infections; Drug Resistance, Viral; Humans; Organophosphonates; Organophosphorus Compounds; Retroviridae Infections; Tenofovir	2003
Antiviral therapy for adenovirus infections. Antiviral research, 2006, Volume: 71, Issue:2-3 Topics: Adenovirus Infections, Human; Adenoviruses, Human; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Humans; Immunocompromised Host; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Organophosphonates; Ribavirin	2006
Cidofovir in the treatment of poxvirus infections. Antiviral research, 2002, Volume: 55, Issue:1 Topics: Administration, Intranasal; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; DNA, Viral; Humans; Immunocompromised Host; Injections, Intraperitoneal; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Poxviridae; Poxviridae Infections	2002
Value of animal models to evaluate agents with potential activity against human cytomegalovirus. Transplantation proceedings, 1991, Volume: 23, Issue:3 Suppl 3 Topics: Acyclovir; Animals; Antiviral Agents; Cell Division; Cell Survival; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Fibroblasts; Ganciclovir; Humans; Mice; Organophosphonates; Organophosphorus Compounds; Virus Replication	1991

Other Studies

70 other study(ies) available for cidofovir anhydrous and Disease Models, Animal

Article	Year
Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2 Topics: Administration, Oral; Animals; Benzamides; Disease Models, Animal; Female; Indoles; Isoindoles; Mice; Organ Specificity; Orthopoxvirus; Poxviridae Infections; Time Factors; Treatment Outcome; Virus Replication	2007
Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir. Bioorganic & medicinal chemistry letters, 2011, Jul-01, Volume: 21, Issue:13 Topics: Administration, Oral; Alanine; Animals; Antiviral Agents; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Molecular Structure; Organophosphonates; Peptides; Prodrugs; Rats; Serine; Valine	2011
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49 Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection	2020
Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection Model. Molecules (Basel, Switzerland), 2021, Jun-05, Volume: 26, Issue:11 Topics: A549 Cells; Adenoviridae Infections; Adenoviruses, Human; Administration, Topical; Animals; Cidofovir; Dendrimers; Disease Models, Animal; Eye Infections, Viral; Female; Humans; Polylysine; Rabbits; Treatment Outcome; Viral Load	2021
HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model. Viruses, 2017, 06-13, Volume: 9, Issue:6 Topics: A549 Cells; Adenoviridae Infections; Adenovirus Infections, Human; Adenoviruses, Human; Animals; Antiviral Agents; Cell Line; Cidofovir; Cricetinae; Cytosine; Disease Models, Animal; Ganciclovir; Humans; Immunosuppression Therapy; Liver; Male; Organophosphonates; Valganciclovir; Viral Load; Virus Replication	2017
Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models. Vaccine, 2017, 07-24, Volume: 35, Issue:33 Topics: Animals; Antibodies, Viral; Antiviral Agents; CD4-Positive T-Lymphocytes; Cidofovir; Cytosine; Dermatitis, Atopic; Disease Models, Animal; Ectromelia virus; Female; Humans; Kaposi Varicelliform Eruption; Mice; Organophosphonates; Smallpox Vaccine	2017
Lytic viral replication and immunopathology in a cytomegalovirus-induced mouse model of secondary hemophagocytic lymphohistiocytosis. Virology journal, 2017, 12-19, Volume: 14, Issue:1 Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Dexamethasone; Disease Models, Animal; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Lymphohistiocytosis, Hemophagocytic; Mice; Mice, Inbred BALB C; Mice, Knockout; Muromegalovirus; Organophosphonates; T-Lymphocytes; Toll-Like Receptor 3; Toll-Like Receptor 9; Virus Diseases; Virus Replication	2017
Safety of cidofovir by intratympanic delivery technique. Antiviral therapy, 2014, Volume: 19, Issue:1 Topics: Animals; Antiviral Agents; Cidofovir; Cochlea; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hearing Loss, Sensorineural; Injections; Organophosphonates	2014
Reduced tumorigenicity and pathogenicity of cervical carcinoma SiHa cells selected for resistance to cidofovir. Molecular cancer, 2013, Dec-10, Volume: 12 Topics: Animals; Antineoplastic Agents; Antiviral Agents; Apoptosis; Cell Line, Tumor; Cidofovir; Cytosine; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Resistance, Viral; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Mice; Mice, Nude; Organophosphonates; Phenotype; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2013
In vitro efficacy of brincidofovir against variola virus. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9 Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cidofovir; Cytosine; Disease Models, Animal; DNA, Viral; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Organophosphonates; Smallpox; Variola virus	2014
Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless mice. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1 Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Drug Therapy, Combination; Female; Immunoglobulins; Infusions, Parenteral; Mice, Hairless; Mice, SCID; Organophosphonates; Skin Diseases, Infectious; Treatment Outcome; Vaccinia	2015
Papiine herpesvirus 2 as a predictive model for drug sensitivity of Macacine herpesvirus 1 (monkey B virus). Comparative medicine, 2014, Volume: 64, Issue:5 Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Disease Models, Animal; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Cercopithecine; Macaca mulatta; Mice; Organophosphonates; Simplexvirus; Trifluridine; Vero Cells; Viral Plaque Assay	2014
Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model. Antiviral research, 2014, Volume: 112 Topics: Adenoviridae Infections; Adenoviruses, Human; Alanine Transaminase; Animals; Body Weight; Cell Line; Cidofovir; Cytosine; Disease Models, Animal; Female; Humans; Immunocompromised Host; Liver; Mesocricetus; Organophosphonates; Ribavirin; Survival Analysis; Treatment Outcome; Viral Load	2014
The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease. Antiviral research, 2015, Volume: 117 Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Humans; Injections, Intradermal; Organophosphonates; Rabbits; Random Allocation; Smallpox; Vaccinia; Vaccinia virus; Variola virus	2015
In Vitro and In Vivo Evaluation of Cidofovir as a Topical Ophthalmic Antiviral for Ocular Canine Herpesvirus-1 Infections in Dogs. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2015, Volume: 31, Issue:10 Topics: Administration, Ophthalmic; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Disease Models, Animal; Dog Diseases; Dogs; Herpesviridae Infections; Herpesvirus 1, Canid; Madin Darby Canine Kidney Cells; Microscopy, Confocal; Organophosphonates; Random Allocation; Vero Cells; Virus Shedding	2015
Effect of high-dose vocal fold injection of cidofovir and bevacizumab in a porcine model. The Laryngoscope, 2017, Volume: 127, Issue:3 Topics: Animals; Bevacizumab; Biopsy, Needle; Cidofovir; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunohistochemistry; Injections, Intralesional; Laryngeal Neoplasms; Odds Ratio; Organophosphonates; Papilloma; Random Allocation; Sensitivity and Specificity; Sus scrofa; Vocal Cords	2017
Assessing the efficacy of cidofovir against herpesvirus-induced genital lesions in goats using different therapeutic regimens. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Animals; Antiviral Agents; Base Sequence; Cidofovir; Cytosine; Disease Models, Animal; DNA Primers; DNA, Viral; Female; Genital Diseases, Female; Goat Diseases; Goats; Herpes Genitalis; Herpesviridae Infections; Humans; Organophosphonates; Species Specificity; Vaginal Creams, Foams, and Jellies; Varicellovirus	2008
Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus. Virology, 2009, Jan-05, Volume: 383, Issue:1 Topics: Animal Structures; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Hemorrhage; Humans; Monkeypox virus; Mpox (monkeypox); Myoxidae; Necrosis; Organophosphonates; Smallpox Vaccine	2009
Clinical evaluation of local ocular toxicity in candidate anti-adenoviral agents in vivo. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2009, Volume: 223, Issue:4 Topics: Adenoviridae Infections; Animals; Antiviral Agents; Cidofovir; Conjunctiva; Conjunctivitis, Viral; Cytosine; Disease Models, Animal; Eyelids; Female; Lacrimal Apparatus; Ophthalmic Solutions; Organophosphonates; Rabbits	2009
The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections. Investigative ophthalmology & visual science, 2009, Volume: 50, Issue:11 Topics: Adenoviridae Infections; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agents; Cidofovir; Conjunctivitis, Viral; Cytosine; Disease Models, Animal; Female; Humans; Organophosphonates; Rabbits; Tumor Cells, Cultured; Viral Plaque Assay; Virus Replication; Zalcitabine	2009
Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Investigative ophthalmology & visual science, 2011, Volume: 52, Issue:1 Topics: Adenoviridae; Adenoviridae Infections; Animals; Anti-Infective Agents, Local; Cidofovir; Conjunctiva; Conjunctivitis, Viral; Cytosine; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Ophthalmic Solutions; Organophosphonates; Pharmaceutical Preparations; Povidone-Iodine; Rabbits; Tobramycin; Treatment Outcome; Viral Plaque Assay	2011
Cidofovir does not prevent caprine herpesvirus type-1 neural latency in goats. Antiviral therapy, 2010, Volume: 15, Issue:5 Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; DNA, Viral; Female; Ganglia; Goats; Herpesviridae Infections; Humans; Organophosphonates; Sacrococcygeal Region; Varicellovirus; Virus Latency; Virus Shedding	2010
Evaluation of inhaled cidofovir as postexposure prophylactic in an aerosol rabbitpox model. Antiviral research, 2012, Volume: 93, Issue:1 Topics: Administration, Inhalation; Animals; Antiviral Agents; Cell Line; Cidofovir; Cytosine; Disease Models, Animal; Female; Lung; Male; Organophosphonates; Post-Exposure Prophylaxis; Rabbits; Vaccinia; Vaccinia virus	2012
A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease. Virology journal, 2012, Jun-18, Volume: 9 Topics: Animals; Antibodies, Viral; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Ectromelia virus; Ectromelia, Infectious; Female; Immunoglobulin G; Interferon-gamma; Mice; Mice, Inbred BALB C; Organophosphonates; Survival Analysis	2012
HPMPC therapy of MCMV-induced retinal disease in the SCID mouse measured by electroretinography, a non-invasive technique. Antiviral research, 2003, Volume: 59, Issue:3 Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Models, Animal; Electroretinography; Eye Infections, Viral; Female; Herpesviridae Infections; Humans; Mice; Mice, SCID; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Retina; Treatment Outcome; Virus Replication	2003
Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10 Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Viral; Female; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Vaccinia; Vero Cells	2003
The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir. Antiviral research, 2004, Volume: 61, Issue:1 Topics: Adenoviridae Infections; Adenoviruses, Human; Administration, Topical; Animals; Antigens, Viral; Antiviral Agents; Cidofovir; Conjunctivitis, Viral; Cornea; Cytosine; Disease Models, Animal; Drug Evaluation, Preclinical; Eye Infections, Viral; Female; Organophosphonates; Organophosphorus Compounds; Rats; Sigmodontinae; Viral Plaque Assay; Virus Replication; Virus Shedding	2004
Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model. Virology, 2004, Jan-20, Volume: 318, Issue:2 Topics: Administration, Oral; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Ectromelia virus; Ectromelia, Infectious; Esters; Female; Inhibitory Concentration 50; Mice; Molecular Structure; Organophosphonates; Organophosphorus Compounds	2004
Efficacy of cidofovir in a murine model of disseminated progressive vaccinia. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6 Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; DNA, Viral; Mice; Mice, Nude; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; Skin; Vaccinia; Vaccinia virus	2004
Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir. Antiviral research, 2004, Volume: 63, Issue:1 Topics: Administration, Cutaneous; Animals; Antiviral Agents; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; Mice; Organophosphonates; Organophosphorus Compounds; Orthopoxvirus; Vaccinia; Vaccinia virus	2004
Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue. Antiviral research, 2004, Volume: 63, Issue:1 Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Disease Models, Animal; Ganciclovir; Humans; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Transplantation, Heterologous; Virus Replication	2004
Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection. The Journal of infectious diseases, 2004, Aug-01, Volume: 190, Issue:3 Topics: Administration, Oral; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Esters; Ether; Humans; Lipids; Male; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Prodrugs; Treatment Outcome	2004
Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice. The Journal of infectious diseases, 2004, Sep-15, Volume: 190, Issue:6 Topics: Administration, Topical; Animals; Antiviral Agents; Brain; Cidofovir; Cyclophosphamide; Cytosine; Disease Models, Animal; Female; Immunocompromised Host; Immunosuppressive Agents; Injections, Intraperitoneal; Kidney; Liver; Lung; Mice; Mice, Hairless; Organophosphonates; Organophosphorus Compounds; Skin; Specific Pathogen-Free Organisms; Spleen; Survival Analysis; Time Factors; Vaccinia; Viral Plaque Assay	2004
Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice. Antiviral chemistry & chemotherapy, 2005, Volume: 16, Issue:3 Topics: Animals; Cells, Cultured; Cidofovir; Cytosine; Disease Models, Animal; Drug Resistance; Mice; Mice, Inbred BALB C; Mice, SCID; Mutation; Organophosphonates; Vaccinia; Vaccinia virus; Virus Replication	2005
Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model. Virology journal, 2006, Mar-01, Volume: 3 Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Female; Guinea Pigs; Infectious Disease Transmission, Vertical; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Roseolovirus; Roseolovirus Infections	2006
N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model. Investigative ophthalmology & visual science, 2006, Volume: 47, Issue:5 Topics: Adenoviridae; Adenoviridae Infections; Animals; Antiviral Agents; Cidofovir; Cornea; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Eye Infections, Viral; Female; Keratitis; Ophthalmic Solutions; Organophosphonates; Rabbits; Taurine; Viral Plaque Assay; Virus Replication	2006
Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection. Antiviral research, 2006, Volume: 72, Issue:2 Topics: Animals; Antiviral Agents; Cidofovir; Cowpox; Cytokines; Cytosine; Disease Models, Animal; Female; Lung; Mice; Mice, Inbred BALB C; Organophosphonates; Vaccinia; Vaccinia virus	2006
The effect of cidofovir on cytomegalovirus-induced hearing loss in a Guinea pig model. Archives of otolaryngology--head & neck surgery, 2006, Volume: 132, Issue:6 Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Evoked Potentials, Auditory; Guinea Pigs; Hearing Loss; Organophosphonates; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction	2006
Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12 Topics: Administration, Intranasal; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Disease Models, Animal; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Genes, Viral; Mice; Mice, Inbred BALB C; Mutation; Organophosphonates; Phenotype; Specific Pathogen-Free Organisms; Vaccinia; Vaccinia virus; Vero Cells	2006
Cidofovir is effective against caprine herpesvirus 1 infection in goats. Antiviral research, 2007, Volume: 74, Issue:2 Topics: Animals; Cidofovir; Cytosine; Disease Models, Animal; Goats; Herpesviridae Infections; Organophosphonates; Varicellovirus; Virus Shedding	2007
In vivo imaging of cidofovir treatment of cowpox virus infection. Virus research, 2007, Volume: 128, Issue:1-2 Topics: Animals; Antiviral Agents; Bioterrorism; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; DNA Replication; Drug Evaluation, Preclinical; Female; Green Fluorescent Proteins; Humans; Image Processing, Computer-Assisted; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Organophosphonates; Recombination, Genetic; Smallpox; Treatment Outcome; Vero Cells; Virus Replication	2007
A model of human cytomegalovirus infection in severe combined immunodeficient mice. Antiviral research, 2007, Volume: 76, Issue:2 Topics: Animals; Antiviral Agents; Cell Culture Techniques; Cell Line; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Ganciclovir; Gelatin Sponge, Absorbable; Humans; Male; Mice; Mice, SCID; Organophosphonates; Viral Plaque Assay	2007
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox. Journal of virology, 2007, Volume: 81, Issue:20 Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Humans; Organophosphonates; Poxviridae Infections; Rabbits; Smallpox; Survival Rate; Vaccinia; Vaccinia virus; Viremia	2007
DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions. Antiviral therapy, 2007, Volume: 12, Issue:5 Topics: Adenine; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Disease Models, Animal; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Enzyme Inhibitors; Exodeoxyribonucleases; Foscarnet; Genotype; Herpes Simplex; Herpesvirus 1, Human; Humans; Mice; Models, Molecular; Mutation; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Phenotype; Protein Binding; Protein Conformation; Vero Cells; Viral Proteins; Virulence	2007
Efficacy of topical immunoglobulins against experimental adenoviral ocular infection. Investigative ophthalmology & visual science, 2007, Volume: 48, Issue:9 Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agents; Cell Culture Techniques; Cidofovir; Conjunctiva; Cornea; Cytosine; Disease Models, Animal; Epithelial Cells; Eye Infections, Viral; Flow Cytometry; Immunoglobulins, Intravenous; Immunologic Factors; Keratoconjunctivitis; Organophosphonates; Rabbits; Treatment Outcome; Virus Cultivation; Virus Replication; Virus Shedding	2007
Recovery of humoral immunity is critical for successful antiviral therapy in disseminated mouse adenovirus type 1 infection. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: 3T3 Cells; Adenoviridae; Adenoviridae Infections; Animals; Antibodies, Viral; Antiviral Agents; Cell Line; Cidofovir; Cyclophosphamide; Cytosine; Disease Models, Animal; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, SCID; Organophosphonates; Treatment Outcome	2008
Long-term therapy for herpes retinitis in an animal model with high-concentrated liposome-encapsulated HPMPC. Archives of ophthalmology (Chicago, Ill. : 1960), 1995, Volume: 113, Issue:5 Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Electroretinography; Eye Infections, Viral; Fundus Oculi; Herpes Simplex; Liposomes; Longitudinal Studies; Organophosphonates; Organophosphorus Compounds; Rabbits; Retinitis	1995
HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model. Cornea, 1994, Volume: 13, Issue:6 Topics: Administration, Topical; Animals; Antiviral Agents; Cells, Cultured; Chlorocebus aethiops; Cidofovir; Cytosine; Disease Models, Animal; Female; Herpesvirus 1, Human; Keratitis, Dendritic; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Rabbits; Trifluridine; Vero Cells; Virus Replication	1994
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice. Journal of medical virology, 1993, Volume: 41, Issue:3 Topics: Animals; Antiviral Agents; Brain; Cidofovir; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney; Liver; Lung; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Vaccinia; Vaccinia virus; Virus Replication	1993
Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:2 Topics: Animals; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Ganciclovir; Immunohistochemistry; Lung; Male; Organophosphonates; Organophosphorus Compounds; Paraffin Embedding; Pneumonia, Viral; Rats; Whole-Body Irradiation	1993
Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs. Antiviral research, 1993, Volume: 21, Issue:1 Topics: Acyclovir; Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Female; Guinea Pigs; Herpes Genitalis; Mice; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Ultraviolet Rays; Vagina; Vaginal Diseases; Virus Replication	1993
Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis. The Journal of infectious diseases, 1996, Volume: 173, Issue:1 Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Drug Carriers; Eye Infections, Viral; Herpes Simplex; Herpesvirus 1, Human; Injections; Liposomes; Organophosphonates; Organophosphorus Compounds; Rabbits; Retina; Retinitis; Vitreous Body	1996
Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral research, 1996, Volume: 31, Issue:3 Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antibodies, Viral; Cidofovir; Cytosine; Disease Models, Animal; Drug Evaluation; Enzyme-Linked Immunosorbent Assay; Eye; Female; Humans; Organophosphonates; Organophosphorus Compounds; Rabbits; Tears; Tumor Cells, Cultured	1996
An ocular model of Adenovirus type 5 infection in the rabbit. Bulletin de la Societe belge d'ophtalmologie, 1995, Volume: 259 Topics: Adenine; Adenoviridae; Adenoviridae Infections; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Eye Diseases; Organophosphonates; Organophosphorus Compounds; Rabbits; Virus Replication	1995
Effective treatment of experimental cytomegalovirus-induced encephalo-meningitis in immunocompromised rats with HPMPC. Antiviral research, 1997, Volume: 35, Issue:2 Topics: Animals; Antiviral Agents; Brain; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Drug Therapy, Combination; Ganciclovir; Immune Sera; Immunocompromised Host; Male; Meninges; Meningitis, Viral; Organophosphonates; Organophosphorus Compounds; Rats; Rats, Inbred BN; Time Factors	1997
An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects. Experimental eye research, 1997, Volume: 64, Issue:5 Topics: Animals; Cidofovir; Ciliary Body; Corneal Diseases; Cytosine; Disease Models, Animal; Eye Diseases; Guinea Pigs; Intraocular Pressure; Iritis; Microscopy, Electron; Organophosphonates; Organophosphorus Compounds; Pigment Epithelium of Eye; Retina; Retinal Diseases; Uveal Diseases	1997
Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis. Archives of ophthalmology (Chicago, Ill. : 1960), 1998, Volume: 116, Issue:6 Topics: Acyclovir; Animals; Antiviral Agents; Cidofovir; Cornea; Cytosine; Disease Models, Animal; Female; Guanine; Herpesvirus 1, Human; Keratitis, Herpetic; Male; Ointments; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Rabbits; Trifluridine	1998
Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis. Antiviral research, 1999, Dec-31, Volume: 44, Issue:3 Topics: Alanine Transaminase; Animals; Antiviral Agents; Aspartate Aminotransferases; Body Weight; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Female; Ganciclovir; Hepatitis, Viral, Animal; Herpesviridae Infections; Liver; Mice; Mice, Inbred BALB C; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Virus Replication	1999
Topical effects of cidofovir on cutaneous rabbit warts: treatment regimen and inoculum dependence. Antiviral research, 2000, Volume: 46, Issue:2 Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cottontail rabbit papillomavirus; Cytosine; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Organophosphonates; Organophosphorus Compounds; Rabbits; Time Factors; Warts	2000
In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas. Antiviral research, 2000, Volume: 48, Issue:2 Topics: Animals; Antiviral Agents; Cidofovir; Cottontail rabbit papillomavirus; Cytosine; Disease Models, Animal; Humans; Nucleosides; Organophosphonates; Organophosphorus Compounds; Papilloma; Papillomavirus Infections; Rabbits; Treatment Outcome; Tumor Virus Infections	2000
Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:5 Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Ganciclovir; Herpesviridae Infections; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Muromegalovirus; Myocarditis; Organophosphonates; Organophosphorus Compounds	2001
Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir. Antiviral chemistry & chemotherapy, 2001, Volume: 12, Issue:1 Topics: Administration, Intranasal; Animals; Antiviral Agents; Cidofovir; Cowpox virus; Cytosine; Disease Models, Animal; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Injections, Subcutaneous; Lung; Mice; Mice, Inbred BALB C; Nose; Organ Specificity; Organophosphonates; Organophosphorus Compounds; Paranasal Sinuses; Pneumonia, Viral; Spleen; Vaccinia; Vaccinia virus; Viral Load; Viremia	2001
Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections. Antiviral chemistry & chemotherapy, 2001, Volume: 12 Suppl 1 Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Ganciclovir; Humans; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Virus Replication	2001
Bioterrorism. Blocking smallpox: a second defense. Science (New York, N.Y.), 2001, Oct-19, Volume: 294, Issue:5542 Topics: Animals; Antiviral Agents; Bioterrorism; Cidofovir; Cytosine; Disease Models, Animal; Disease Outbreaks; Humans; Macaca fascicularis; Military Medicine; Organophosphonates; Organophosphorus Compounds; Smallpox; Smallpox Vaccine; United States; Variola virus; World Health Organization	2001
Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model. Antiviral research, 2001, Volume: 52, Issue:3 Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Cidofovir; Conjunctivitis, Viral; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Eye; Female; Organophosphonates; Organophosphorus Compounds; Rabbits; Virus Cultivation; Virus Replication	2001
Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug. Antiviral research, 2002, Volume: 54, Issue:2 Topics: Animals; Antiviral Agents; Area Under Curve; Body Weight; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; Female; Lung; Mice; Mice, Inbred BALB C; Nasal Mucosa; Organophosphonates; Organophosphorus Compounds; Prodrugs; Purines; Statistics, Nonparametric; Vero Cells	2002
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice. Journal of medical virology, 1992, Volume: 37, Issue:1 Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ganciclovir; Male; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds	1992
Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:9 Topics: Animals; Antifungal Agents; Antineoplastic Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Drug Combinations; Ganciclovir; Immunologic Deficiency Syndromes; Interferon Type I; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Organophosphonates; Organophosphorus Compounds; Recombinant Proteins	1992
Pretreatment with topical 0.1% (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine inhibits adenovirus type 5 replication in the New Zealand rabbit ocular model. Cornea, 1992, Volume: 11, Issue:6 Topics: Adenoviridae; Adenoviridae Infections; Animals; Antiviral Agents; Cidofovir; Colony Count, Microbial; Corneal Diseases; Corneal Stroma; Cytosine; Disease Models, Animal; Eye Infections, Viral; Female; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Premedication; Rabbits; Virus Replication	1992
(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis. Investigative ophthalmology & visual science, 1991, Volume: 32, Issue:6 Topics: Animals; Antiviral Agents; Bromodeoxyuridine; Cidofovir; Cytosine; Disease Models, Animal; Drug Administration Schedule; Female; Keratitis, Dendritic; Male; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Rabbits; Random Allocation; Simplexvirus; Thymidine Kinase	1991